Alain Luxembourg
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)
Publications by Year
Research Areas
Cervical Cancer and HPV Research, Hepatitis B Virus Studies, Immunotherapy and Immune Responses, Genital Health and Disease, Animal Virus Infections Studies
Most-Cited Works
- → A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women(2015)1,394 cited
- → Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16–26 years: a randomised, double-blind trial(2017)452 cited
- → Immunogenicity of the 9-Valent HPV Vaccine Using 2-Dose Regimens in Girls and Boys vs a 3-Dose Regimen in Women(2016)205 cited
- → Final analysis of a 14-year long-term follow-up study of the effectiveness and immunogenicity of the quadrivalent human papillomavirus vaccine in women from four nordic countries(2020)186 cited
- → Attribution of 12 High-Risk Human Papillomavirus Genotypes to Infection and Cervical Disease(2014)180 cited
- → Immunogenicity and Safety of a 9-Valent HPV Vaccine(2015)132 cited